NKMAX Co. Ltd. 13D and 13G filings for NKGen Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-19 1:41 pm Sale | 2023-12-13 | 13D | NKGEN BIOTECH INC NKGN | NKMAX Co. Ltd. | 12,917,057 53.180% | -2,453,576 (-15.96%) | Filing |
| 2023-10-10 5:01 pm Purchase | 2023-09-29 | 13D | NKGEN BIOTECH INC NKGN | NKMAX Co. Ltd. | 15,370,633 63.400% | 15,370,633 (New Position) | Filing |